Skybiotech Healthcare share news and announcements
BSE: 512036Textiles & ApparelsSmall Cap
Last close ₹116.50down ₹0.50 (0.43%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹117.00.
52-week range of traded prices to 23 Oct 2026
₹113.90Low, 28 Sep 2026₹218.20High, 2 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹22 Cr3,866th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 2.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.91
- Volume, BSEVolume. Shares traded on the last trading day.
- 25
Skybiotech Healthcare board meetings
125 filed, newest first. Page 3 of 3.
Aug 2019
6 Aug · Board meeting
Meeting on 14 Aug 2019: quarterly results
May 2019
30 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2019: audited results and dividend
Mar 2019
Jan 2019
30 Jan · Board meeting
Meeting on 11 Feb 2019: quarterly results
Nov 2018
Aug 2018
May 2018
Feb 2018
13 Feb · Board meeting
Dec 2017
Sep 2017
May 2017
31 May · Board meeting
Aug 2016
12 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 12, 2016, inter alia, has transacted the following; The board also accepts ....
Sep 2015
5 Sep · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2015, inter alia, has : - Appointment of Mr. Prakash Rao as a independent ....
Mar 2015
30 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 30, 2015, has taken the following decisions: 1. Appoint Mrs. Pankti Bhansali ....
Sep 2011
6 Sep · Board meeting
Board of Directors of the Company at its meeting held on August 29, 2011, inter alia, has taken the following decision; 1. To issue up to ....
Mar 2011
24 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 18, 2011, has taken the following decisions: 1. To issue up to 4,00,000 Equity ....10 Mar · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2011, inter alia, has taken the following decision: 1. To issue up ....
Feb 2010
5 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 01, 2010, inter alia, has decided to issue up to 4,00,000 Equity share on a preferential ....